Zhaofeng Shi

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
On the background of high morbidity and mortality of hepatocellular carcinoma (HCC) and rapid development of traditional Chinese medicine (TCM), we conducted a systematic review and meta-analysis of randomized clinical trials (RCTs) according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement to assess the clinical(More)
  • 1